Работы, цитирующие эту работу

Работ: 5

Работа: Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure

1. Effective influence of sacubutril/valsartan on systolic function of left ventricle in patients with heart failure and a reduced ejеction fraction

   Ikbol Adilova, Gulnoza Akbarova

   СтатьяHeart Failure Treatment and ManagementОбщество и инновации2021Цитирований: 0

   ABIABI:AkademIndex/openalex/2021.article.006024

2. Overview of Sodium-Glucose Co-transporter 2 (SGLT2) Inhibitors for the Treatment of Non-diabetic Heart Failure Patients

   Irina Balan, Tetyana Khayo, Sevara Sultanova +1

   Обзорная статьяDiabetes Treatment and ManagementCureus2021Цитирований: 0

   ABIABI:AkademIndex/openalex/2021.review-article.000026

3. Eurasian guidelines for the prevention and treatment of cardiovascular diseases in patients with obesity (2022)

   И Е Чазова, Yu. V. Zhernakova, N. V. Blinova +19

   СтатьяCardiac Health and Mental HealthEurasian heart journal2022Цитирований: 0

   ABIABI:AkademIndex/openalex/2022.article.000532

4. Treatment of Chronic Heart Failure with a Low Ejection Fraction with Sacubitril/Valsartan (Uperio) on the Background of Diabetes Mellitus

   I.K. Abdullaev, R.B. Fayzullayev, J.I. Reymberganov

   СтатьяHeart Failure Treatment and ManagementJournal of Pharmaceutical Negative Results2022Цитирований: 0

   ABIABI:AkademIndex/openalex/2022.article.008642

5. Eurasian guidelines for the prevention and treatment of cardiovascular diseases in patients with obesity (2022)

   И Е Чазова, Yu. V. Zhernakova, N. V. Blinova +20

   СтатьяCardiac Health and Mental HealthEurasian heart journal2022Цитирований: 0

   ABIABI:AkademIndex/openalex/2022.article.009850